Pharma & Biotech

Harvard Bioscience shares experienced a significant decline following the release of disappointing quarterly earnings, yet a deeper examination of the...

CervoMed is confronting a severe financial crisis that threatens its very existence. The biopharmaceutical company's latest quarterly report discloses staggering...

The survival of 23AndMe Holding Co. hangs by a thread as the company navigates Chapter 11 bankruptcy proceedings under its...

Rallybio has delivered a stunning financial turnaround that caught market observers by surprise. The biotechnology company reported a net profit...

Pluri Inc. finds itself at a pivotal moment as the biotechnology firm prepares to release quarterly results on Monday. With...

The landscape of American pharmacy retail has undergone a fundamental change as Walgreens Boots Alliance completes its transition to private...

The telehealth provider Hims & Hers finds itself at a critical juncture, presenting a complex financial picture where robust revenue...

Viking Therapeutics is generating significant attention in the biotech sector with new clinical findings for its experimental weight-loss treatment, VK2735....

In a surprising market development, shares of Crinetics Pharmaceuticals are experiencing notable gains despite the company reporting disappointing quarterly financial...

The fate of Xoma Royalty's proposed acquisition of LAVA Therapeutics hangs in the balance as shareholders convene for a decisive...